LakePharma ups biologics offering with Massachusetts site
CDMO LakePharma has acquired a former-Stryker facility in Massachusetts to boost clinical biomanufacturing services.
CDMO LakePharma has acquired a former-Stryker facility in Massachusetts to boost clinical biomanufacturing services.
ADC Bio has developed a concurrent conjugation and antibody purification process, not reliant on Protein A capture resin.
Lonza will combine its cell and gene therapy capabilities through four centres of excellence worldwide, following a number of investments in the space.